Mexico clears for use the world's first dengue fever vaccine
Now that the world's first dengue vaccine has won regulatory approval in Mexico, health officials there estimate it will prevent 8,000 hospitalizations and 104 deaths a year.
As many as 400 million people around the globe are infected with dengue every year, the World Health Organization says, and it is endemic in more than 100 countries. It's the fastest-growing mosquito-borne disease in the world and has no known cure, and kids are particularly at risk of becoming infected. There are four separate strains of dengue, and the deadliest form kills 22,000 people every year.
Researchers had to come up with a vaccine that could immunize people against each strain, and clinical tests of 40,000 participants from 15 countries found that the vaccine can immunize two-thirds of people 9 years old and up. The vaccine, Dengvaxia, is manufactured by the French company Sanofi, which has requested regulatory approval in 20 countries across Latin America and Asia. The price hasn't been decided yet, but the head of Sanofi's vaccines division says it could generate more than $1 billion a year in revenue, Agence France-Presse reports. Mexico's National Vaccination Council will soon convene to determine if the country will start giving residents Dengvaxia for free, said Mikel Arriola, the head of the regulatory agency. "It's a great step forward," he told AFP.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Roasted squash and apple soup recipeThe Week Recommends Autumnal soup is full of warming and hearty flavours
-
Ukraine: Donald Trump pivots againIn the Spotlight US president apparently warned Volodymyr Zelenskyy to accept Vladimir Putin’s terms or face destruction during fractious face-to-face
-
Autumn Budget: will Rachel Reeves raid the rich?Talking Point To fill Britain’s financial black hole, the Chancellor will have to consider everything – except an income tax rise
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
